Stockscreener 앱 받기
0.7673
2.93%
-0.0243
시간 외 거래:
.77
0.0027
+0.35%
전일 마감가:
$0.7916
열려 있는:
$0.8
하루 거래량:
585.85K
Relative Volume:
1.89
시가총액:
$32.28M
수익:
$3.26M
순이익/손실:
$-19.52M
주가수익비율:
-1.9183
EPS:
-0.4
순현금흐름:
$-24.10M
1주 성능:
-3.95%
1개월 성능:
-26.12%
6개월 성능:
-12.30%
1년 성능:
-49.45%
1일 변동 폭
$0.76
$0.808
1주일 범위
$0.732
$0.8198
52주 변동 폭
$0.66
$1.62
Scynexis Inc Stock (SCYX) Company Profile
명칭
Scynexis Inc
전화
201-884-5485
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
SCYX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.77 | 33.19M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
141.09 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.99 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-22 | 개시 | Guggenheim | Buy |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-07-11 | 업그레이드 | Needham | Hold → Buy |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2017-07-10 | 개시 | ROTH Capital | Buy |
| 2017-05-09 | 다운그레이드 | Needham | Buy → Hold |
| 2017-03-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-20 | 개시 | H.C. Wainwright | Buy |
| 2016-10-07 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | 재개 | Brean Capital | Buy |
| 2016-08-17 | 개시 | Guggenheim | Buy |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-08-09 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | 개시 | Brean Capital | Buy |
| 2015-12-29 | 개시 | WBB Securities | Speculative Buy |
| 2015-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-06-10 | 개시 | Needham | Buy |
| 2014-05-29 | 개시 | Canaccord Genuity | Buy |
| 2014-05-29 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Scynexis Inc 주식(SCYX)의 최신 뉴스
Trend analysis for SCYNEXIS Inc. this weekJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Building trade automation scripts for SCYNEXIS Inc.July 2025 Sentiment & Technical Confirmation Alerts - newser.com
Has SCYNEXIS Inc. found a price floorJuly 2025 Update & High Accuracy Trade Alerts - newser.com
Technical signs of recovery in SCYNEXIS Inc.Stop Loss & Safe Entry Momentum Tips - newser.com
What momentum shifts mean for SCYNEXIS Inc.Bear Alert & Daily Entry Point Trade Alerts - newser.com
Why SCYNEXIS Inc. stock remains resilientWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
How SCYNEXIS Inc. stock reacts to Fed rate cuts2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Can SCYNEXIS Inc. (135A) stock attract analyst upgradesJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
SCYNEXIS Inc. recovery potential after sell offJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Why SCYNEXIS Inc. (135A) stock could rally stronglyWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
How strong is SCYNEXIS Inc. (135A) stock earnings growthWatch List & Daily Entry Point Trade Alerts - newser.com
What data driven models say about SCYNEXIS Inc.’s futureJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Multi asset correlation models including SCYNEXIS Inc.July 2025 Recap & Expert Curated Trade Ideas - newser.com
What institutional flow reveals about SCYNEXIS Inc.Long Setup & Reliable Intraday Trade Alerts - newser.com
Evaluating SCYNEXIS Inc. with trendline analysisJuly 2025 PostEarnings & Weekly High Return Opportunities - newser.com
Metagenomi (NASDAQ:MGX) versus SCYNEXIS (NASDAQ:SCYX) Head-To-Head Analysis - Defense World
Will SCYNEXIS Inc. stock go up soonJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Is SCYNEXIS Inc. reversing from oversold territoryJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
SCYNEXIS announces favourable Phase I data for SCY-247 trial - Yahoo Finance
SCYNEXIS reports positive Phase 1 results for antifungal drug SCY-247 - Investing.com Nigeria
What drives SCYNEXIS Inc 135A stock priceAnalyst Downgrades & Learn to Trade with Real-Time Feedback - earlytimes.in
Scynexis Inc (SCYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
1.16%
자본화:
|
볼륨(24시간):